APP and Alzheimer disease: Genetic markers; such as mutations in the gene of amyloid precursor protein (APP), presenilin 1 and 2 (PS1 and PS2) and tau, were identified for early onset AD, while apolipoprotein E (APOE) and clusterin gene (CLU) mutations were identified for the late onset form [15,16].